InsidersTradesSigma
Track the Enorama Pharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Enorama Pharma AB has published 2 reports. Market capitalisation: €24.6m. The latest transaction was disclosed on 23 December 2025 (Other). Among the most active insiders: Ara Abrahamian. The full history is free.
2
Insider Decl.
n/a
Thresholds
€795,981
1 ops.
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 December 2025
Declarations2 total
125,000 shares0AktieISIN SE0008216329FI:A003V025-1
3,811,481 shares@ €0.20883.76% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0021629151FI:A003S139-1
2 of 2 declarations
About Enorama Pharma AB
Enorama Pharma AB is a company focused on developing innovative pharmaceutical products, particularly in the field of addiction treatments. It is listed on the Stockholm Stock Exchange.